BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
latest_posts
- 1
These 45 exoplanets may be the best places to search for alien life - 2Humpback whale stranded on Germany's Baltic coast frees itself
- 3Israel Police decry online defamation campaign against female officer in Jerusalem
- 4Figure out how to Guarantee Your Dental Embeds Endure forever
- 5Doctors looking into hormone therapy as a way to ward off dementia in women
- Figuring out Significant Regulations and Guidelines for Organizations
- A mom stopped giving her kids snacks — and sparked a debate about eating habits
- We analyzed Philly street scenes and identified signs of gentrification using machine learning trained on longtime residents’ observations
- German finance minister seeks better market access in China talks
- Vote In favor of Your Number one Kind Of Food Conveyance Administration
- Mobility exercises are an important part of fitness as we age. Here are some tips
- This St Nick Truly Can Advise How To Drink And Hack Your Headache
- 10 Demonstrated Tips to Expand Your New Android Cell phone: A Thorough Aide
- Northern lights chances rise for Christmas as space weather remains unsettled
